Xeris Biopharma Holdings, Inc.
XERS
Revenue
60.10M
▲5.83M▲10.74%
3 Months ChangeAssets
323.06M
▲1.96M▲0.6091%
3 Months ChangeLiabilities
352.68M
▲3.25M▲0.9295%
3 Months ChangeFree Cash Flow
-96.62M
▼-15.69M▼-19.38%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-08
Form 10-Q
ID: 0001867096-24-000162
2024-08-08
Form 8-K
ID: 0001867096-24-000157
2024-08-02
Form 8-K
ID: 0001867096-24-000137
2024-07-08
Form 8-K
ID: 0001867096-24-000124
2024-06-05
Form 8-K
ID: 0001867096-24-000102
2024-05-09
Form 10-Q
ID: 0001867096-24-000065
2024-05-09
Form 8-K
ID: 0001867096-24-000062
2024-03-06
Form 8-K
ID: 0001867096-24-000024
2024-01-04
Form 8-K
ID: 0001867096-24-000003
2023-11-09
Form 10-Q
ID: 0001867096-23-000139